Golimumab is a monoclonal antibody against TNFa, which is known to be involved in autophagy regulation in a variety of cells, such as synovial fibroblasts of patients with rheumatoid arthritis (Connor et al., 2012) and atherosclerotic vascular smooth cells (Jia et al., 2006). Here, TNF is linked to rheumatoid arthritis.